Multidrug-resistant HIV

AIDS Reader

Volumn 15, Issue 6, 2005, Pages 266-267

  Laurence, Jeffrey ^a,b  

^a Department of Medicine ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antiretroviral therapy; Drug resistance; HIV AIDS; Risk behavior

Indexed keywords

LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EDITORIAL; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; RISK ASSESSMENT; TREATMENT FAILURE; UNITED KINGDOM; VIRUS LOAD; VIRUS RESISTANCE; COMPARATIVE STUDY; FEMALE; MALE; MICROBIOLOGICAL EXAMINATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANTI-HIV AGENTS; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 20544470926     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Markowitz M, Mohri H, Mehandru S, et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet. 2005; 365:1031-1038.
2. Laurence J. Possible HIV "super-strain" in New York City; new human T-lymphotropic viruses identified in Africa. AIDS Reader. 2005;15:155-156.
3. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.
4. Phillips AN, Dunn D, Sabin C, et al; UK Collaborative Group on HIV Drug Resistance; UK CHIC Study Group. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS. 2005;19:487-494.
5. Sabin CA, Hill T, Lampe F, et al. Treatment exhaustion of highly active anti-retroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study. BMJ. 2005;30:695.
6. Richman DD, Morton SC, Wrin T, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS. 2004;18:1393-1401.
7. Chase M. Researchers working to develop treatments for patients initially infected with drug-resistant HIV strains. Wall Street Journal. February 23, 2005.
8. Lightfoot M, Swendeman D, Rotheram-Borus MJ, et al. Risk behaviors of youth living with HIV: pre-and post-HAART. Am J Health Behav. 2005;29:162-171.
9. Kershaw TS, Ickovics JR, Lewis JB, et al. Sexual risk following a sexually transmitted disease diagnosis: the more things change the more they stay the same. J Behav Med. 2004;27:445-461.
10. Ven PE, Mao L, Fogarty A, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS. 2005;19:179-184.
11. Miles J. Unprotected sex still a problem for gay men. Australian Associated Press. February 9, 2005.
12. Murri R. Highly active antiretroviral therapy. BMJ. 2005;330:681-682.